Focus (Desert Biologicals, Inc.)


Welcome to the PulseAid listing for the Focus drug offered from Desert Biologicals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Desert Biologicals, Inc.
NON-PROPRIETARY NAME: Adenosinum Triphosphoricum Dinatrum, Alpha-Ketoglutaricum Acidum, Formicum Acidum, Malicum Acidum, Sarcolacticum Acid, Dulcamara, Hyoscyamus Niger, Phosphorus, Sabina, Acetylcholine Chloride, Adrenali
SUBSTANCE NAME: ADENOSINE TRIPHOSPHATE DISODIUM; OXOGLURIC ACID; FORMIC ACID; MALIC ACID; LACTIC ACID, L-; SOLANUM DULCAMARA TOP; HYOSCYAMUS NIGER; PHOSPHORUS; JUNIPERUS SABINA LEAFY TWIG; ACETYLCHOLINE CHLORIDE; EPI
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2016-04-22
END MARKETING DATE: 0000-00-00


Focus HUMAN OTC DRUG Details:

Item DescriptionFocus from Desert Biologicals, Inc.
LABELER NAME: Desert Biologicals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 8; 8; 8; 8; 8; 8; 8; 30; 30; 30; 30; 30; 30; 30([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [h)
START MARKETING DATE: 2016-04-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43742-0733_c45d31e1-cfd5-4316-af5e-c97b66f0597d
PRODUCT NDC: 43742-0733
APPLICATION NUMBER:

Other ADENOSINE TRIPHOSPHATE DISODIUM; OXOGLURIC ACID; FORMIC ACID; MALIC ACID; LACTIC ACID, L-; SOLANUM DULCAMARA TOP; HYOSCYAMUS NIGER; PHOSPHORUS; JUNIPERUS SABINA LEAFY TWIG; ACETYLCHOLINE CHLORIDE; EPI Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Deseret Biologicals, Inc.Focus
Desert Biologicals, Inc.Focus